Brian Schwenk is Chief Financial Officer and Chief Compliance Officer at Philadelphia-based 1315. Organization, location and related investors we track.
Brian Schwenk is Chief Financial Officer and Chief Compliance Officer at Philadelphia-based 1315 Capital, joining the firm in 2014 after finance and accounting roles at Quaker Partners, Independence Capital Partners, and audit firms. His documented responsibilities center on financial reporting, treasury, compliance, risk management, investor relations, and firm operations rather than leading investments. 1315 Capital invests in commercial-stage healthcare companies across healthcare services, specialty pharmaceutical and medical-device products, outsourcing, and health and wellness. Public sources describe the firm’s target investments as roughly $10–30 million, while another directory reports a broader $5–50 million range. No reliable source found here establishes Schwenk’s individual lead/follow behavior or geographic investment mandate. Named 1315 Capital portfolio companies include Biocoat, Colorescience, Onkos Surgical, Centurion Service Group, and Reaction Biology. The available sources do not identify public investment writing or a distinctive personal investment viewpoint attributable to Schwenk.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Philadelphia.
Investors like Brian Schwenk · Full investor directory · Investor access · Company funding database
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide